查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1736510

全球CHO細胞衍生性乙肝疫苗市場－按類型、應用、地區和預測的市場規模

Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size By Type, By Application, By Geographic Scope And Forecast
出版日期: | 出版商: Verified Market Research | 英文 | 商品交期: 2-3個工作天內

價格
簡介目錄

CHO細胞衍生性B型肝炎疫苗市場規模及預測

近年來，CHO細胞衍生性乙肝疫苗市場發展迅速，預計在市場估計和預測期（2026-2032年）內將大幅成長。

定義CHO細胞衍生性B肝疫苗的全球市場

CHO細胞衍生的乙肝疫苗用於預防B肝病毒感染。相關症狀包括尿液呈現深色、發燒、腹痛、噁心和嘔吐。乙肝病毒會損害肝臟等身體部位，引發慢性和急性疾病。該疫苗被認為可有效防止感染擴散。此疫苗廣泛應用於診所和醫院。

CHO細胞衍生性B型肝炎疫苗全球市場概況

報告的市場展望部分涵蓋了市場的基本動態，主要包括市場面臨的促進因素、限制因素、機會和挑戰。市場促進因素和限制因素是內在因素，而市場促進因素和挑戰是外在因素。

由於全球乙肝感染率不斷上升，CHO細胞衍生性B型肝炎疫苗市場正經歷顯著成長。此外，政府鼓勵CHO疫苗的措施也為市場成長帶來了樂觀的前景。此外，研發活動的活性化也推動了市場的成長。然而，該疫苗的一些潛在缺陷預計將阻礙市場的成長。

驗證市場研究利用一手資料來縮小可用數據範圍，檢驗數據，並編制一份全面的市場研究報告。該報告包含對客戶感興趣的市場因素的定量和定性評估。全球CHO細胞衍生性B型肝炎疫苗市場主要分為兩個細分市場，可提供有關市場最新趨勢的分類資料。

目錄

第1章全球CHO細胞衍生性B型肝炎疫苗市場簡介

  • 市場概覽
  • 研究範圍
  • 先決條件

第2章執行摘要

第3章：已驗證的市場研究調查方法

  • 資料探勘
  • 驗證
  • 第一手資料
  • 資料來源列表

第4章 CHO 細胞衍生性乙肝疫苗的全球市場展望

  • 概述
  • 市場動態
    • 驅動程式
    • 限制因素
    • 機會
  • 波特五力模型
  • 價值鏈分析

5. 全球CHO細胞衍生性B肝疫苗市場（按類型）

  • 概述
  • 成人
  • 兒科

6. 全球CHO細胞衍生性乙肝疫苗市場（依應用）

  • 概述
  • 診所
  • 醫院

7. 全球CHO細胞衍生性B肝疫苗市場（按地區）

  • 概述
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 其他亞太地區
  • 世界其他地區
    • 拉丁美洲
    • 中東

8. 全球CHO細胞衍生性B型肝炎疫苗市場：競爭格局

  • 概述
  • 各公司市場排名
  • 主要發展策略

第9章 公司簡介

  • Merck & Co. Inc.
  • Sanofi Pasteur
  • Emergent Biosolutions
  • Serum Institute of India
  • GlaxoSmithKline Plc.
  • CSL Limited
  • Pfizer Inc.
  • Johnson & Johnson

第10章 附錄

  • 相關調查
簡介目錄
Product Code: 37234

Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size And Forecast

Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market size is growing at a faster pace with substantial growth rates over the last few years and is estimated that the market will grow significantly in the forecasted period i.e. 2026 to 2032.

Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Definition

The Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine is used to protect the viral infection caused by Hepatitis B. The virus is highly transmissible through contact with a body fluid such as blood. The symptoms associated, include dark urine, fever, abdominal pain, nausea and vomiting, and many others. It results in affecting the body parts such as the liver in response causes chronic and acute diseases. This vaccine is considered to be an effective solution to the prevention of spread. It widely finds its application in the clinic and hospitals.

Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Overview

In the report, the market outlook section mainly encompasses fundamental dynamics of the market which include drivers, restraints, opportunities and challenges faced by the industry. Drivers and restraints are intrinsic factors whereas opportunities and challenges are extrinsic factors of the market.

The Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market is experiencing tremendous growth owing to the growing prevalence of the Hepatitis B infection all over the globe. In addition, the government initiatives in encouraging the CHO vaccines are imposing a positive outlook on the market growth. Furthermore, the upsurge in the R&D activities is fueling the market growth. However, the invisible disadvantages of the vaccines are expected to hamper the growth of the market.

Verified Market Research narrows down the available data using primary sources to validate the data and use it in compiling a full-fledged market research study. The report contains a quantitative and qualitative estimation of market elements that interests the client. The "Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market" is mainly bifurcated into sub-segments which can provide classified data regarding the latest trends in the market.

Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Segmentation Analysis

The Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market is Segmented on the basis of Type, Application, And Geography.

Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market, By Type

  • Adult Hepatitis B (CHO) Vaccine
  • Pediatric Hepatitis B (CHO) Vaccine

Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market, By Application

  • Clinics
  • Hospitals

Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of The World

Key Players

  • Merck & Co. Inc.,
  • Sanofi Pasteur
  • Emergent Biosolutions
  • Serum Institute of India
  • GlaxoSmithKline Plc.
  • CSL Limited, Pfizer Inc.
  • Johnson & Johnson.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL RECOMBINANT HAMSTER OVARY CELL (CHO) HEPATITIS B VACCINE MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL RECOMBINANT HAMSTER OVARY CELL (CHO) HEPATITIS B VACCINE MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL RECOMBINANT HAMSTER OVARY CELL (CHO) HEPATITIS B VACCINE MARKET, BY TYPE

  • 5.1 Overview
  • 5.2 Adult Hepatitis B (CHO) Vaccine
  • 5.3 Pediatric Hepatitis B (CHO) Vaccine

6 GLOBAL RECOMBINANT HAMSTER OVARY CELL (CHO) HEPATITIS B VACCINE MARKET, BY APPLICATION

  • 6.1 Overview
  • 6.2 Clinics
  • 6.3 Hospitals

7 GLOBAL RECOMBINANT HAMSTER OVARY CELL (CHO) HEPATITIS B VACCINE MARKET, BY GEOGRAPHY

  • 7.1 Overview
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 U.K.
    • 7.3.3 France
    • 7.3.4 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Rest of Asia Pacific
  • 7.5 Rest of the World
    • 7.5.1 Latin America
    • 7.5.2 Middle East

8 GLOBAL RECOMBINANT HAMSTER OVARY CELL (CHO) HEPATITIS B VACCINE MARKET COMPETITIVE LANDSCAPE

  • 8.1 Overview
  • 8.2 Company Market Ranking
  • 8.3 Key Development Strategies

9 COMPANY PROFILES

  • 9.1 Merck & Co. Inc.
    • 9.1.1 Overview
    • 9.1.2 Financial Performance
    • 9.1.3 Product Outlook
    • 9.1.4 Key Developments
  • 9.2 Sanofi Pasteur
    • 9.2.1 Overview
    • 9.2.2 Financial Performance
    • 9.2.3 Product Outlook
    • 9.2.4 Key Developments
  • 9.3 Emergent Biosolutions
    • 9.3.1 Overview
    • 9.3.2 Financial Performance
    • 9.3.3 Product Outlook
    • 9.3.4 Key Developments
  • 9.4 Serum Institute of India
    • 9.4.1 Overview
    • 9.4.2 Financial Performance
    • 9.4.3 Product Outlook
    • 9.4.4 Key Developments
  • 9.5 GlaxoSmithKline Plc.
    • 9.5.1 Overview
    • 9.5.2 Financial Performance
    • 9.5.3 Product Outlook
    • 9.5.4 Key Developments
  • 9.6 CSL Limited
    • 9.6.1 Overview
    • 9.6.2 Financial Performance
    • 9.6.3 Product Outlook
    • 9.6.4 Key Developments
  • 9.7 Pfizer Inc.
    • 9.7.1 Overview
    • 9.7.2 Financial Performance
    • 9.7.3 Product Outlook
    • 9.7.4 Key Developments
  • 9.8 Johnson & Johnson
    • 9.8.1 Overview
    • 9.8.2 Financial Performance
    • 9.8.3 Product Outlook
    • 9.8.4 Key Developments

10 Appendix

  • 10.1 Related Research